Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Krammick, "RU 486 and the Politics of Drug Regulation in the United States and France". Cornell International Law Journal. 1992
The drug's French manufacturer, Roussel-Uclaff, has stated that it has no current plans to apply to the United States Food and Drug Administration (FDA) for a license to market the drug in the United States. 14 The reasons for the French company's refusal to market the drug in the United States, however, extend beyond the threat of boycotts.

This Note will focus on the political, legal, and regulatory dynamics underlying the contrasting stories of the availability of RU 486 in France and its non-availability in the United States. This Note suggests that the crucial difference in the two pictures is that the French government through active governmental intervention in the pharmaceutical market has insulated the issue of drug availability and public health from political and religious views on abortion, whereas the U.S. government has not....

oh.
by Cat on Fri Dec 17th, 2021 at 08:04:51 PM EST
[ Parent ]

Others have rated this comment as follows:

Display:

Top Diaries

Occasional Series